This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Compugen Ltd. Corporation. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- D. N. Negev, IL (2013)
- Kibbuttz Kfar Aza, IL (2016)
Company Filing History:
Years Active: 2013-2016
Title: Anat Amir: Innovator in Biopharmaceuticals
Introduction
Anat Amir is a prominent inventor based in D.N. Negev, Israel. She has made significant contributions to the field of biopharmaceuticals, holding a total of 4 patents. Her work focuses on developing innovative therapeutic solutions that address various medical conditions.
Latest Patents
Anat Amir's latest patents include groundbreaking advancements in peptide therapies. One of her notable inventions is related to angiopoietin-derived peptides. This patent provides a pharmaceutical composition that includes these peptides, which can be used for therapy and the manufacture of medicaments. It also outlines methods for treating a wide range of conditions, disorders, and diseases using these peptides, along with nucleotide sequences encoding them and antibodies directed to their epitopes.
Another significant patent involves clusterin-derived peptides. This invention encompasses pharmaceutical compositions that include these peptides, as well as methods for manufacturing them. The patent also details methods for treating various conditions by administering these peptides and their derivatives, along with nucleotide sequences and antibodies related to them.
Career Highlights
Anat Amir is currently associated with Compugen Ltd. Corporation, where she continues to advance her research and development efforts in the biopharmaceutical sector. Her innovative work has positioned her as a key player in the industry, contributing to the development of novel therapeutic agents.
Collaborations
Anat has collaborated with notable colleagues, including Ofer Levy and Yossef Kliger. These partnerships have further enhanced her research capabilities and have led to significant advancements in her field.
Conclusion
Anat Amir's contributions to biopharmaceuticals through her innovative patents and collaborations highlight her role as a leading inventor in the industry. Her work continues to pave the way for new therapeutic solutions that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile